| Particulars (Rupees in Crores.) | Dec-2024 | Dec-2023 |
|---|---|---|
Gross Sales | 3,062.61 | 3,233.97 |
Excise Duty | 0 | 0 |
Net Sales | 3,062.61 | 3,233.97 |
Other Operating Income | 0 | 0 |
Other Income | 43.06 | 23.78 |
Total Income | 3,105.67 | 3,257.76 |
Total Expenditure | 2,692.04 | 3,140.23 |
PBIDT | 413.62 | 117.53 |
Interest | 30.06 | 38.24 |
PBDT | 383.57 | 79.29 |
Depreciation | 113.45 | 91.69 |
Minority Interest Before NP | 0 | 0 |
Tax | 60.5 | 67.46 |
Deferred Tax | 15.45 | -120.11 |
Reported Profit After Tax | 194.17 | 40.26 |
Minority Interest After NP | 3.61 | 2.97 |
Net Profit after Minority Interest | 190.56 | 37.29 |
Extra-ordinary Items | 6.1 | 41.21 |
Adjusted Profit After Extra-ordinary item | 184.46 | -3.92 |
EPS (Unit Curr.) | 12.84 | 2.61 |
Book Value (Unit Curr.) | 0 | 0 |
Dividend (%) | 0 | 0 |
Equity | 30.62 | 28.61 |
Public Shareholding (Number) | 0 | 0 |
Public Shareholding (%) | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 |
PBIDTM(%) | 13.5 | 3.63 |
PBDTM(%) | 12.52 | 2.45 |
PATM(%) | 6.34 | 1.24 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
